Quick Answer
Tenon Medical, Inc. reported Cash and Equivalents of $3.76 million for fiscal year 2025.
Tenon Medical, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $3.76M | -42.5% |
| 2024 | $6.54M | +169.2% |
| 2023 | $2.43M | +14.0% |
| 2022 | $2.13M | -27.0% |
| 2021 | $2.92M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.44M | -62.4% | -56.1% |
| June 30, 2025 | $7.85M | +298.7% | -23.9% |
| March 31, 2025 | $10.31M | +135.0% | +57.8% |
| December 31, 2024 | $6.54M | +169.2% | -28.7% |
| September 30, 2024 | $9.16M | +171.8% | +365.5% |
| June 30, 2024 | $1.97M | -66.4% | -55.2% |
| March 31, 2024 | $4.39M | +38.0% | +80.7% |
| December 31, 2023 | $2.43M | +14.0% | -28.0% |
- Tenon Medical, Inc. showed a decrease of -42.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2021–2025 period, Tenon Medical, Inc.’s cash and equivalents has grown by 28.8% (from $2.92 million to $3.76 million).
- The most recent figure is from Tenon Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: